Company
Headquarters: Beijing, China
Employees: 621
CN¥4.98 Billion
CNY as of Jan. 1, 2024
US$700.6 Million
| Company | Market Cap (USD) |
|---|---|
| Zoetis Inc. | $89.09 B |
| MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
| Takeda Pharmaceutical Company Limited | $47.71 B |
| Haleon plc | $38.90 B |
| PPD, Inc. | $16.58 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Beijing Science Sun Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of injections in China. It offers products for cardiovascular, cerebrovascular, immunomodulatory, nervous systems, and other areas. The company was founded in 1999 and is headquartered in Beijing, China.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Beijing Science Sun Pharmaceutical Co. Ltd has the following listings and related stock indices.
Stock: SZSE: 300485 wb_incandescent